A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population

Abstract Kidneys are affected by human immunodeficiency virus (HIV) infection and its associated therapies. Antiretroviral therapy (ART) has markedly reduced acquired immune deficiency syndrome–related deaths and opportunistic infectious diseases among HIV-infected patients. This contributed to thei...

Full description

Bibliographic Details
Main Authors: Minoru Ando, Yoko Ando
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Renal Replacement Therapy
Subjects:
Online Access:https://doi.org/10.1186/s41100-019-0245-4
_version_ 1818623534800306176
author Minoru Ando
Yoko Ando
author_facet Minoru Ando
Yoko Ando
author_sort Minoru Ando
collection DOAJ
description Abstract Kidneys are affected by human immunodeficiency virus (HIV) infection and its associated therapies. Antiretroviral therapy (ART) has markedly reduced acquired immune deficiency syndrome–related deaths and opportunistic infectious diseases among HIV-infected patients. This contributed to their prolonged survival; however, the improvement in survival has been accompanied by an increase in the incidence of non-infectious chronic complications, including hypertension, metabolic diseases, and chronic kidney disease (CKD). Recent studies showed that estimated prevalence of any CKD and end-stage renal disease (ESRD) among HIV-infected patients is approximately 20% and 0.5%, respectively, in Japan. Both a rapid decrease in renal function and a high positive rate of albuminuria and proteinuria are clinical characteristics of HIV-infected patients. Moreover, considering higher complication rates of hypertension and diabetes compared with non-HIV-infected individuals of the similar aging, HIV-infected patients who develop CKD and ESRD are very likely to increase. Furthermore, as the survival rate is favorable after the initiation of dialysis, the cumulative number of ESRD patients is supposed to increase. The corporation for treatment of HIV-positive hemodialysis patients by general dialysis clinics will be urgently required; however, there still remain some preoccupations and prejudices about HIV per se in Japan, which may provoke hesitation from accepting those patients.
first_indexed 2024-12-16T18:42:36Z
format Article
id doaj.art-eb011fa1ab0a41d28ab360fdd6cbf4df
institution Directory Open Access Journal
issn 2059-1381
language English
last_indexed 2024-12-16T18:42:36Z
publishDate 2019-12-01
publisher BMC
record_format Article
series Renal Replacement Therapy
spelling doaj.art-eb011fa1ab0a41d28ab360fdd6cbf4df2022-12-21T22:20:58ZengBMCRenal Replacement Therapy2059-13812019-12-01511910.1186/s41100-019-0245-4A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected populationMinoru Ando0Yoko Ando1Department of Medicine, Jiseikai Memorial HospitalDivision of Health Care, Kanto-Shinetsu Regional Taxation BureauAbstract Kidneys are affected by human immunodeficiency virus (HIV) infection and its associated therapies. Antiretroviral therapy (ART) has markedly reduced acquired immune deficiency syndrome–related deaths and opportunistic infectious diseases among HIV-infected patients. This contributed to their prolonged survival; however, the improvement in survival has been accompanied by an increase in the incidence of non-infectious chronic complications, including hypertension, metabolic diseases, and chronic kidney disease (CKD). Recent studies showed that estimated prevalence of any CKD and end-stage renal disease (ESRD) among HIV-infected patients is approximately 20% and 0.5%, respectively, in Japan. Both a rapid decrease in renal function and a high positive rate of albuminuria and proteinuria are clinical characteristics of HIV-infected patients. Moreover, considering higher complication rates of hypertension and diabetes compared with non-HIV-infected individuals of the similar aging, HIV-infected patients who develop CKD and ESRD are very likely to increase. Furthermore, as the survival rate is favorable after the initiation of dialysis, the cumulative number of ESRD patients is supposed to increase. The corporation for treatment of HIV-positive hemodialysis patients by general dialysis clinics will be urgently required; however, there still remain some preoccupations and prejudices about HIV per se in Japan, which may provoke hesitation from accepting those patients.https://doi.org/10.1186/s41100-019-0245-4AlbuminuriaCystatin CEstimated glomerular filtration rateProteinuriaUrinary biomarker
spellingShingle Minoru Ando
Yoko Ando
A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
Renal Replacement Therapy
Albuminuria
Cystatin C
Estimated glomerular filtration rate
Proteinuria
Urinary biomarker
title A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
title_full A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
title_fullStr A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
title_full_unstemmed A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
title_short A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
title_sort high likelihood of increase in end stage renal disease among the japanese hiv infected population
topic Albuminuria
Cystatin C
Estimated glomerular filtration rate
Proteinuria
Urinary biomarker
url https://doi.org/10.1186/s41100-019-0245-4
work_keys_str_mv AT minoruando ahighlikelihoodofincreaseinendstagerenaldiseaseamongthejapanesehivinfectedpopulation
AT yokoando ahighlikelihoodofincreaseinendstagerenaldiseaseamongthejapanesehivinfectedpopulation
AT minoruando highlikelihoodofincreaseinendstagerenaldiseaseamongthejapanesehivinfectedpopulation
AT yokoando highlikelihoodofincreaseinendstagerenaldiseaseamongthejapanesehivinfectedpopulation